Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions

Healthy

Interventions

DRUG

LC15-0444

LC15-0444 50mg qd (8 days once daily)

DRUG

Metformin

Metformin 1000 mg bid (8 days twice daily)

DRUG

LC15-0444+Metformin

LC15-0444 50mg qd (8 days once daily) + Metformin 1000 mg bid (8 days twice daily)

Trial Locations (1)

Seoul National University Hospital, Seoul